Clarity Pharmaceuticals Ltd
ASX:CU6
Clarity Pharmaceuticals Ltd
Revenue
Clarity Pharmaceuticals Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Revenue
AU$11.7m
|
CAGR 3-Years
59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Mayne Pharma Group Ltd
ASX:MYX
|
Revenue
AU$190.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Revenue
AU$237.6m
|
CAGR 3-Years
550%
|
CAGR 5-Years
77%
|
CAGR 10-Years
47%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Revenue
AU$588.4k
|
CAGR 3-Years
56%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Revenue
AU$221.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
Arovella Therapeutics Ltd
ASX:ALA
|
Revenue
AU$435.9k
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Clarity Pharmaceuticals Ltd's Revenue?
Revenue
11.7m
AUD
Based on the financial report for Jun 30, 2023, Clarity Pharmaceuticals Ltd's Revenue amounts to 11.7m AUD.
What is Clarity Pharmaceuticals Ltd's Revenue growth rate?
Revenue CAGR 3Y
59%
Over the last year, the Revenue growth was 78%. The average annual Revenue growth rates for Clarity Pharmaceuticals Ltd have been 59% over the past three years .